Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel L Aitken

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 14, 2017
Significant publications on infectious diseases pharmacotherapy in 2015Jessica T Babic, Amelia Sofjan, Margaret Babin, et al.
Open Forum Infectious Diseases|May 27, 2024
Implementation of an Automated Antibiotic Time-out at a Comprehensive Cancer CenterFrank P Tverdek, Samuel L Aitken, Victor E Mulanovich, et al.
Plos One|July 25, 2014
Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, TexasSamuel L Aitken, Tiby B Joseph, Dhara N Shah, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2015
Age-Stratified Treatment Response Rates in Hospitalized Patients with Clostridium difficile Infection Treated with MetronidazoleVy P Pham, Andrea M Luce, Sara C Ruppelt, et al.
Open Forum Infectious Diseases|August 10, 2018
Clinical Outcomes Associated With Linezolid Resistance in Leukemia Patients With Linezolid-Resistant <i>Staphylococcus epidermidis</i> BacteremiaStephanie A Folan, Kayleigh R Marx, Frank P Tverdek, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 7, 2015
Significant publications on infectious diseases pharmacotherapy in 2014Kady Phe, Richard M Cadle, David J Guervil, et al.
The Pediatric Infectious Disease Journal|June 3, 2016
Use of Ceftolozane/Tazobactam in the Treatment of Multidrug-resistant Pseudomonas aeruginosa Bloodstream Infection in a Pediatric Leukemia PatientSamuel L Aitken, Dimitrios P Kontoyiannis, April M DePombo, et al.
The Journal of Infection|November 16, 2016
Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposureAdam J DiPippo, Frank P Tverdek, Jeffrey J Tarrand, et al.
Open Forum Infectious Diseases|October 30, 2023
In Vivo Emergence of Pandrug-Resistant <i>Acinetobacter baumannii</i> Strain: Comprehensive Resistance Characterization and Compassionate Use of Sulbactam-DurlobactamMollie VanNatta, Laurie Grier, Muhammad H Khan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2020
Alterations of the Oral Microbiome and Cumulative Carbapenem Exposure Are Associated With Stenotrophomonas maltophilia Infection in Patients With Acute Myeloid Leukemia Receiving ChemotherapySamuel L Aitken, Pranoti V Sahasrabhojane, Dimitrios P Kontoyiannis, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 14, 2017
Significant publications on infectious diseases pharmacotherapy in 2015Jessica T Babic, Amelia Sofjan, Margaret Babin, et al.
Open Forum Infectious Diseases|May 27, 2024
Implementation of an Automated Antibiotic Time-out at a Comprehensive Cancer CenterFrank P Tverdek, Samuel L Aitken, Victor E Mulanovich, et al.
Plos One|July 25, 2014
Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, TexasSamuel L Aitken, Tiby B Joseph, Dhara N Shah, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2015
Age-Stratified Treatment Response Rates in Hospitalized Patients with Clostridium difficile Infection Treated with MetronidazoleVy P Pham, Andrea M Luce, Sara C Ruppelt, et al.
Open Forum Infectious Diseases|August 10, 2018
Clinical Outcomes Associated With Linezolid Resistance in Leukemia Patients With Linezolid-Resistant <i>Staphylococcus epidermidis</i> BacteremiaStephanie A Folan, Kayleigh R Marx, Frank P Tverdek, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 7, 2015
Significant publications on infectious diseases pharmacotherapy in 2014Kady Phe, Richard M Cadle, David J Guervil, et al.
The Pediatric Infectious Disease Journal|June 3, 2016
Use of Ceftolozane/Tazobactam in the Treatment of Multidrug-resistant Pseudomonas aeruginosa Bloodstream Infection in a Pediatric Leukemia PatientSamuel L Aitken, Dimitrios P Kontoyiannis, April M DePombo, et al.
The Journal of Infection|November 16, 2016
Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposureAdam J DiPippo, Frank P Tverdek, Jeffrey J Tarrand, et al.
Open Forum Infectious Diseases|October 30, 2023
In Vivo Emergence of Pandrug-Resistant <i>Acinetobacter baumannii</i> Strain: Comprehensive Resistance Characterization and Compassionate Use of Sulbactam-DurlobactamMollie VanNatta, Laurie Grier, Muhammad H Khan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2020
Alterations of the Oral Microbiome and Cumulative Carbapenem Exposure Are Associated With Stenotrophomonas maltophilia Infection in Patients With Acute Myeloid Leukemia Receiving ChemotherapySamuel L Aitken, Pranoti V Sahasrabhojane, Dimitrios P Kontoyiannis, et al.
Pageof 11